entertainment -WSS

entertainment

author：hotspot 2025-09-29 22:53:59 - browse：64889

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today, we explore the future of obesity drugs and how they’re named, we chat with CRISPR pioneers about what it’s like to see the technology approved for human use, and more.

The need-to-know this morning:
• Bayer said it prematurely stopped a Phase 3 study in stroke prevention after independent monitors concluded its experimental blood-thinning medicine, called asundexian, showed inferior efficacy compared to a standard treatment. The asundexian study setback is a significant blow to Bayer’s effort to revamp its drug-development pipeline, analysts said.
• Carmot Therapeutics filed paperwork Friday for an initial public offering of undisclosed size. The Berkeley, Calif.-based company is developing drugs that target GLP-1 and GIP to treat diabetes and obesity, similar to Novo Nordisk’s Ozempic/Wegovy and Eli Lilly’s Mounjaro/Zepbound.
• Bristol Myers Squibb and 2Seventy Bio said the FDA will not complete an on-time review of its application seeking to expand the use of Abecma, their CAR-T therapy for multiple myeloma. Instead, the FDA will convene an advisory panel meeting — date to be determined — to examine survival data from an Abecma clinical trial.
• The U.K. and the pharmaceutical industry have reached a deal on a five-year plan outlining how the health system pays for drugs, as the country tries to keep a lid on its medicines spending while simultaneously building up its life sciences industry. STAT’s Andrew Joseph has more here.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Truvian presents data for its desktop blood

explore

WSS

The battle over 'scope creep' and who gets to be called 'doctor'

The mammogram wars are not over

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

A new crop of companies is reshaping the health data economy

Ending health disparities requires full federal government, panel says

hotspot

entertainment

focus

Sports medicine is finally prioritizing gender equality

Trump allegedly attempted to have surveillance video deleted: Special Counsel

In age of alternative facts, a scholarly course on calling out crap

Democrats decry new health bill for going easy on private equity

Guidelines to prevent youth baseball injuries need more muscle

What to watch for from Zogenix and Amicus clinical trials

Medicare details structure of new drug price negotiation program

An outrageous hospital charge: I paid $710 for an hour of babysitting

The cancer drug shortage isn’t new — and neither are the solutions

Device maker Teleflex to acquire urology company for $600M

Wikipedia

As the dark side of IVF slowly comes into focus, even more transparency is needed

Trump allegedly attempted to have surveillance video deleted: Special Counsel

The haunting brain science of long Covid

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

New Alzheimer's drugs heat up race for early detection blood tests

Biden to sign 'historic' executive order on how US military handles sexual assault cases

hotspot

explore

hotspot

leisure time